Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Povzetek
Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Ključne besede
extracellular vesicles;SARS-CoV-2;targeted delivery;
Podatki
| Jezik: | Angleški jezik |
|---|---|
| Leto izida: | 2022 |
| Tipologija: | 1.03 - Kratki znanstveni prispevek |
| Organizacija: | UNG - Univerza v Novi Gorici |
| UDK: | 577 |
| COBISS: |
104572419
|
| ISSN: | 2329-0501 |
| Št. ogledov: | 673 |
| Št. prenosov: | 0 |
| Ocena: | 0 (0 glasov) |
| Metapodatki: |
|
Ostali podatki
| URN: | URN:SI:UNG |
|---|---|
| Vrsta dela (COBISS): | Delo ni kategorizirano |
| Strani: | str. 41-42 |
| Zvezek: | ǂVol. ǂ25 |
| Čas izdaje: | Jun. 2022 |
| DOI: | 10.1016/j.omtm.2022.02.003 |
| ID: | 15014142 |
Priporočena dela:
Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
2022,
ni podatka o podnaslovu
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
2021,
ni podatka o podnaslovu
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay
2021,
ni podatka o podnaslovu
Nanobodies
2018,
flexible structures for biotechnological applications
Nanomedicine and immunotherapy
2020,
a step further towards precision medicine for glioblastoma